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The prevalence of congenital heart disease in Europe was re-
cently reported in two major papers. Data from a central data-
base for 29 population-based registries in 16 countries showed a
total prevalence of 8 per 1000.1 The overall detection rate of
non-chromosomal congenital heart disease prenatally was only
20%, although 40%of severe cases were diagnosed before birth.
It was estimated that each year in the European Union 36,000
children are live born with congenital heart disease and another
3000 are diagnosed with congenital heart disease but die as a
result of termination of pregnancy for foetal abnormality. In a
systematic review2 of 114 papers and 24091 867 live births the
prevalence of congenital heart disease increased over time from
0.6/1000 in 1930 to 9.1/1000 after 1995. The rate stabilised in the
past 15 years but equates to 1.35million children born each year
with congenital heart disease. The prevalence was higher in
Europe than in North America.
An increased risk of congenital heart disease was seen with
assisted reproductive techniques using data from the Paris
Registry of Congenital Malformations.3 The higher risk varied
with the method of assisted reproductive technique and the
type of cardiac abnormality. The authors speculate that this
may be due to the reproductive technology or to the underly-
ing reason for infertility of the couple.
2. Genetics
Three-quarters of patients with 22q11.2 deletion syndrome
(22q11.2DS) have congenital heart disease and although it is
common practice to test all children with typical cardiac le-
sions for 22q11.2DS, many adult patients have not been inves-
tigated. An adult population of 479 patients with typical
lesions (tetralogy of Fallot and pulmonary atresia and ventric-
ular septal defect) was reviewed.4 Twenty patients were already
known to have 22q11.2DS but a microdeletion was detected in
a further 24 patients. The authors consider that as the syn-
drome has important clinical and reproductive implications,
genetic testing should be considered in all adult patients with
tetralogy of Fallot and pulmonary atresia with ventricular sep-
tal defect.
Tetralogy of Fallot is common in individuals with hemizy-
gous deletions of chromosome 22q11.2 that remove the cardiac
transcription factor TBX1. TBX1 exons were sequenced in 93
patients with non-syndromic tetralogy.5 Single nucleotide
polymorphism analysis was performed in 356 patients with
tetralogy, their parents and healthy controls. Three new vari-
ants not present in 1000 chromosomes from healthy ethnically
matched controls were identiﬁed. This study demonstrated
that rare TBX1 variants with functional consequences arepresent in a small proportion of patients with non-syndromic
tetralogy. The thorny issue of the use and interpretation of
genetic tests was reviewed by Caleshu et al.6
Familial transposition of the great arteries was shown to be
caused by multiple mutations in the laterality genes7 in a study
of seven families. This provides evidence that some cases of
familial transposition are caused by mutations in laterality
genes and therefore are part of the same disease spectrum of
heterotaxy syndrome, and argues for an oligogenic or complex
mode of inheritance in these pedigrees. The editorial by
Keavney8 considered this a useful step forward in understand-
ing transposition. Homo-cysteine is known to be an indepen-
dent risk factor for congenital heart disease and genetic
abnormalities which affect homocysteine may be expected to
inﬂuence the incidence of congenital heart problems. This
was demonstrated when a functional variant in methionine
synthase reductase intron-1 signiﬁcantly increased the risk of
congenital heart disease in the Han Chinese population.9
3. Foetal cardiology
Foetal cardiology remains a cornerstone of congenital heart
practise. The paper by Marek et al.10 offered a unique over-
view of prenatal diagnosis in the Czech republic, which by vir-
tue of the strict organisation of the health service enabled a
comprehensive national registry to develop over two decades.
There were some particular successes and in recent years ante-
natal diagnosis of hypoplastic left heart reached 95.8%,
whereas transposition was diagnosed in only 25.6% of cases.
Whether the antenatal development of the cardiac cham-
bers is dependent on ﬂow is debated, but an elegant paper
by Stressig et al. from Bonn11 demonstrated that preferential
ﬂow to the right heart in the setting of a diaphragmatic hernia
does impair left heart development.
Isolated foetal atrioventricular block was reviewed in a
retrospective European study of 175 cases.12 Risk factors for
poor outcome were gestation < 20 weeks, ventricular
rate < 50/min, hydrops and impaired ventricular function.
No signiﬁcant effect of treatment with corticosteroids was
seen. In a multicentre French study,13 141 patients with non-
immune atrioventricular block, diagnosed in utero or up to
age 15 years, were followed up long term and showed surpris-
ingly good outcomes, with no deaths or dilated cardiomyopa-
thy at a mean follow-up of 11.6 ± 6.7 years.
Atrioventricular block can reﬂect prenatal exposure to
maternal anti-SSA/Ro antibodies and the high mortality asso-
ciated with cardiac neonatal lupus has been shown.14 In a non-
randomised multicentre study of 20 foetuses exposed to mater-
nal lupus antibodies15 it was found that treatment with intra-
venous gamma globulin and steroids potentially improved
Almanac 2012: Congenital heart disease. The national society journals 23the outcome for these children, with better than expected sur-
vival. However, a prospective study of 165 foetuses with
exposure to anti-Ro/La antibody found that foetal atrioventric-
ular prolongation did not predict progression to heart block so
management based on the strategy of identifying and treating
foetal atrioventricular prolongation was questioned.16
Transplacental drug treatment for foetal tachyarrhythmias
was reviewed in a multicentre study,17 which showed the supe-
riority of ﬂecainide and digoxin; however, the study was weak-
ened by being non-randomised.
4. Cardiomyopathy, heart failure and transplantation
Pre-participation screening for cardiomyopathy is gaining
more attention in the media. An Italian study on the value
of pre-participation screening of children with ECGs demon-
strated that postpubertal persistence of T wave inversion was
associated with an increased risk of cardiomyopathy.18
When to propose transplantation remains difﬁcult in ambu-
latory patients. The risk of death and transplantation in paedi-
atric dilated cardiomyopathy was reviewed in a multicentre
database, and the authors showed that an increased left ventric-
ular end-diastolic dimension was associated with an increased
risk of transplantation but not death.19 Work by Giardini
et al.20 has shown that metabolic exercise testing is useful in pre-
dicting prognosis, but the percentages of predicted values are
better than absolute numbers. Transplantation for congenital
heart disease is generally considered a higher risk, although
encouraging results were shown in a small adult congenital
transplant series from the UK.21 An American database review
of over a 1000 transplants for adult congenital heart disease con-
ﬁrmed the high 30-day mortality, but better late survival after
transplantation. Although heart transplants remain a precious
resource,22 at present the results justify the continued expansion
of adult congenital heart transplant programmes.
An international database showed that extracorporeal
membrane oxygenation does not appear to be a reliable
long-term circulatory support for children awaiting heart
transplantation. 23 Fortunately, other options of support exist,
and Stiller et al.24 provide a useful overview of mechanical car-
diovascular support in infants and children.
5. The single ventricle
Patients with a single ventricle remain a great focus for con-
genital heart disease resources. Many controversies exist about
the management of these patients. ACE inhibitors are often
used in this complex circulation, but the effects of their vaso-
dilatation are unclear. Work in children with bidirectional
cavopulmonary shunts demonstrated that enalaprilat did not
increase total cardiac output but redistributed ﬂow to the low-
er body, with a concomitant decrease in arterial oxygen satu-
ration.25 The authors concluded that it is difﬁcult to increase
cardiac output in these patients and ACE inhibitors should
be used with caution in those with borderline aortic satura-
tions. This work ﬁts rather well with the results of a random-
ised multicentre trial, which found administration of enalapril
to infants with single-ventricle physiology in the ﬁrst year of
life did not improve somatic growth, ventricular function or
heart failure severity.26 In a further analysis of their study pop-
ulation, the authors have also shown that the renin aldosteronegenotype inﬂuences ventricular remodelling in infants with a
single ventricle.27
The late outcomes after the Fontan operation remain a con-
cern. In some patients there is a progressive failure of the cir-
culation over time, the underlying pathophysiology of which is
not fully understood. In a review of the current evidence for
alterations in the pulmonary vasculature in Fontan patients,
the potential of treatments approved for pulmonary arterial
hypertension which may provide beneﬁts was discussed.28 Li-
ver disease is now recognised as a serious problem late after
a Fontan operation. Hepatic dysfunction and cirrhotic change
were often seen in a series of Fontan patients.29 Hepatic com-
plications were correlated with the duration of Fontan circula-
tion. The authors concluded that these patients need regular
evaluation of hepatic function, although some non-invasive he-
patic ﬁbrosis markers can be used effectively. At a recent con-
sensus meeting on this problem the group recommended a
prospective study protocol on the assessment of hepatic func-
tion 10 years after a Fontan operation.30
The use of anticoagulation after a Fontan operation re-
mains controversial. A multicentre randomised study of warfa-
rin or heparin after a Fontan procedure was reported.31 A
total signiﬁcant of 111 patients were randomised. There was
a similar, but very, incidence of thrombosis in both groups:
12/57 with aspirin and 13/54 in the warfarin group. Although
there were no differences, the authors concluded that as the
thrombosis rate was so high, alternative approaches should
be considered.
Another Fontan controversy involves the use of fenestra-
tions as although they may improve early surgical results, there
is concern about late complications. The late results for fenes-
tration of the systemic venous pathway at the time of the Fon-
tan operation were reported in a multicentre retrospective non-
randomised study.32 Of the 361 fenestrations, there were few
deleterious later outcomes a mean of 8 ± 3 years after surgery.
Saturations were 89% versus 95% in the fenestrated group.
6. Imaging
Three-dimensional echocardiography is developing rapidly
and its application to congenital heart disease may be one of
its key uses in future years.33 Other emerging imaging methods
include a new high-resolution ultrasound technique.34 The
authors described the technique in adolescents after coarcta-
tion repair in early childhood and demonstrated increased pre-
ductal arterial intima media thickness, left ventricular mass
and ascending aortic stiffness in adolescents. The more pro-
nounced cardiovascular abnormalities after coarctation stent
implantation were felt to be related to older patient age at
the time of intervention.
7. Surgery
The Dutch Congenital Corvitia (CONCOR) registry for adults
with congenital heart disease was reviewed for the results of sur-
gery in predominantly young adults with congenital heart dis-
ease.35 One-ﬁfth required cardiovascular surgery during a 15-
year period and in 40% the surgery was a reoperation.Menwith
congenital heart disease had a higher chance of undergoing sur-
gery in adulthood and had a consistently worse long-term sur-
vival after reoperations in adulthood than women.
24 M. Burch, N. DedieuDetailed functional outcomes 8.1 years (range 2.0–14.0)
after the Ross operation were reported in 45 subjects (aged
24.6 years, range 16.9–52.2 years) who underwent the Ross
procedure between 1994 and 2006. Cardiovascular magnetic
resonance imaging, echocardiography and cardiopulmonary
exercise testing were used.36 The authors demonstrated minor
autograft and homograft dysfunction in the majority of pa-
tients after the Ross procedure, associated with good ventricu-
lar function and exercise capacity. Late survival was compared
in a study of 918 Ross patients and 406 mechanical valve pa-
tients 18–60 years of age who survived an elective procedure
(1994–2008). With the use of propensity score matching, late
survival was compared between the two groups.37 In compara-
ble patients, there was no late survival difference in the ﬁrst
postoperative decade between the Ross procedure and mechan-
ical aortic valve implantation with optimal anticoagulation
self-management. The authors demonstrated that survival in
these selected young adult patients was excellent, perhaps as a
result of highly specialised anticoagulation self-management,
better timing of surgery and improved patient selection in re-
cent years. Despite the advent of the Ross operation, aortic
valve surgery in children remains a complex and difﬁcult area
and a useful overview was provided by d’Udekem.38.
In a report of neurodevelopmental risk from surgery,39 neu-
ropsychological and structural brain imaging assessments in
children 16 years of age with transposition of the great arteries
who underwent the arterial switch operation as infants were re-
viewed. Children were randomly assigned to total circulatory
arrest or continuous low-ﬂow cardiopulmonary bypass but
few signiﬁcant differences between the treatment group were
found. However, adolescents with transposition of the great
arteries who have undergone the arterial switch operation
are at increased neurodevelopmental risk. The authors con-
sider that children with congenital heart disease may beneﬁt
from ongoing surveillance to identify emerging difﬁculties.
8. Tetralogy of fallot
A study using speckle tracking data in patients with corrected
tetralogy of Fallot demonstrated that right ventricular outlet
deformation is delayed, causing a reduction in right ventricular
time delay which is signiﬁcantly related to impairment in right
ventricular performance.40 Late right heart failure is a serious
problem in tetralogy and congenitally corrected transposition.
In a study of 40 of these patients, with myocardial contrast
echocardiography it was found that right ventricular myocar-
dial microvascular density of the septal wall in patients with
hypertrophy due to pressure and/or volume overload is re-
duced. The authors considered that this may be related to a re-
duced myocardial perfusion reserve and impaired right
ventricular systolic function.41 A report on the impact of
restrictive physiology on right ventricular function after repair
of tetralogy found that diastolic right ventricular stiffness was
increased.42 However, the lusitropic response to b adrenergic
agents was abnormal regardless of restrictive physiology. In
an investigation of 29 asymptomatic children with repaired
tetralogy,43 despite moderate right ventricular dilatation and
right bundle branch block compared with controls, the authors
demonstrated neither right ventricular nor left ventricular dys-
synchrony at rest but exercise induced mechanical dyssynchro-
ny. This was unrelated to QRS duration, ventricular volumesand function, or peak oxygen consumption. In a study of
repaired adult tetralogy, left ventricular longitudinal dysfunc-
tion was associated with greater risk of sudden cardiac death
or life-threatening arrhythmias.44 The authors conclude that
in combination with echocardiographic right heart variables,
these measures provided important outcome information for
estimating prognosis.
9. Pulmonary hypertension
Further evidence of the beneﬁts of pulmonary vasodilators in
Eisenmenger syndrome was provided in a prospective open-la-
bel study of sildenaﬁl in 84 patients.45 Twelve months of oral
sildenaﬁl treatment was well tolerated and appeared to im-
prove exercise capacity, systemic arterial oxygen saturation
and haemodynamic parameters in patients with Eisenmenger
syndrome. The importance of pulmonary vasoreactivity as
an independent predictor of outcome in 38 patients with Ei-
sen-menger receiving bosentan was reported.46
A unique national patient cohort of childhood pulmonary
hypertension was reported from theUK.47 The authors showed,
for the ﬁrst time, that the incidence of pulmonary hypertension
is lower in children than adults and that the clinical features can
be different. Most children present with clinical evidence of ad-
vanced disease, and clinical status at presentation is predictive
of outcome. This 7-year experience conﬁrmed the signiﬁcant
improvement in survival over historical controls. The same
group also reported a new CT approach to prognosis.48 They
found that fractal branching quantiﬁes vascular changes and
predicts survival in pulmonary hypertension. The need for pae-
diatric drug development for pulmonary hypertension was
emphasised by Barst.49 A study of patients with Eisenmenger
syndrome (n = 181, age 36.9 ± 12.1 years, 31% with Down’s
syndrome), in whom B-type natriuretic peptide (BNP) concen-
trations were measured as part of routine clinical care, found
they predicted the outcome.50 In addition, the authors specu-
lated that disease-targeting treatments may help to reduce
BNP concentrations in this population, while treatment-naive
patients have static or rising BNP concentrations. This topic
was discussed in more detail in an editorial by D’Alto.51
10. Arterial abnormalities in congenital heart disease
While aortic wall abnormalities have been described in inherited
connective tissue disorders such asMarfan syndrome and bicus-
pid aortic valve disease,52,53 recent reports indicate similar aortic
involvement in classical congenital heart disease entities such as
coarctation of the aorta, tetralogy of Fallot and transposition of
the great arteries; MRI is central in deﬁning the problem.54 Pul-
monary artery dilatation is seen with pulmonary valve abnor-
malities and connective tissue disease, but also occurs in
association with bicuspid aortic valve, in the absence of a pul-
monary valve abnormality, suggesting a primary vessel wall
pathology predisposing to arterial dilatation.55
11. Catheter intervention
With the increased use of interventional cardiological proce-
dures in the young it is clearly important to consider radiation
exposure. Data from Italy raised a concern that children with
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dose of radiation.56 Indirect cancer risk estimations and direct
DNA studies showed that children with congenital heart dis-
ease are exposed to a signiﬁcant radiation dose and empha-
sised the need for strict radiation dose optimisation in
children. The accompanying editorial from Hoffmann and
Bremerich expanded on the risks.57
New developments in catheterisation techniques continue.
A prospective, randomised, multicentre, investigational device
exemption trial in America compared the use of cutting bal-
loons with high-pressure balloons in treating pulmonary artery
stenosis. The authors found a greater efﬁcacy for cutting bal-
loons and a similar safety proﬁle.58 Data from the UK on over
100 stent procedures for coarctation from a single centre,59
demonstrated that stenting for aortic coarctation and re-coarc-
tation is effective with low-immediate complication rates. Post-
procedural aneurysm was rare and stent fractures were not
seen with the newer- generation stents. The optimal method
of follow-up of these patients is unclear with both CT and
MRI considered useful.60 A multicentre observational study
from the USA reported data from 350 children with native
coarctation > 10 kg.61 There were 217 stents, 61 balloon
angioplasties and 72 surgical procedures. Stenting and surgery
were better than balloon angioplasties in reducing upper limb
to lower limb blood pressure gradient at short-term follow-up
and had better integrated aortic arch imaging outcomes. Stent
patients had the shortest stay and the lowest complication rate,
although they were more likely to require a planned interven-
tion. The authors cautioned over interpretation of the results
as the study was not randomised. Balloon angioplasty for aor-
tic arch obstruction is commonly needed after the Norwood
procedure, and results from a retrospective review62 reported
that only 58% of those having an initial balloon angioplasty
were free from arch reintervention at 5 years, with the greatest
risk of reintervention in those < 3 months at initial interven-
tion and those with less successful initial results.
Roberts et al.63 report multicentre experience of successful
percutaneous tricuspid valve replacement using the Melody
valve in 15 patients. All patients had a prior bioprosthetic
valve or conduit in place and had developed signiﬁcant steno-
sis or regurgitation. Encouraging results were reported with
the Edwards SAPIEN transcatheter valve for conduit failure
in the pulmonary position in 36 patients from four centres.64
Helpful images of this device were published by Lauten
et al.65 The outcomes of pre-stenting 1 year after using the
Melody valve in the pulmonary position66 were reported in
65 patients. The early haemodynamic results were sustained
at 1 year, but there was no evidence of further positive func-
tional remodelling after the immediate acute effects.
The strategies surrounding cardiac pacing in infants and
children are often debated. A recent multicentre study showed
that left ventricular pacing was associated with better systolic
function than right ventricular pacing,67 and a useful review
put the problems of pacing in children into context.68
12. Adult congenital heart disease
The expanding population of adults with congenital heart dis-
ease is reﬂected in the increasing numbers of publications in
this ﬁeld. The emerging burden of hospital admissions of
adults with congenital heart disease was described using aDutch national registry.69 During 28 990 patient-years, 2908
patients (50%) were admitted to hospital. Median age at
admission was 39 years (range 18–86). Admission rates were
at least two times higher than in the general population, and
most marked in the older-age groups. With the ageing of this
population, the authors advocate timely preparation of health-
care resources.
A paper from Toronto described the respiratory and skeletal
muscle weakness in adults with congenital heart disease which
resembles that seen in older adults with advanced heart failure.70
The importance of this shift in focus on the mechanisms of re-
duced exercise tolerance in congenital heart disease is further
discussed in the editorial by Giardini.71 Biomarkers may also
have an important role in assessment of these patients. The rela-
tionship of systemic right ventricular function to ECG and NT-
proBNP levels in adults late after the Senning or Mustard pro-
cedure was investigated.72 Circulating NT-proBNP levels and
several surface ECGparameters were shown to constitute surro-
gate markers of systemic right ventricular function and provide
additional information on heart failure status. Although paedi-
atricians are well aware of the association of Down’s syndrome
and congenital heart disease, information from the Netherlands
documented that 17% of patients with Down’s syndrome living
in residential centres had undiagnosed congenital heart disease.
Thirty-one centres and 1158 patients were included in the ﬁrst
stage of the study.73 The authors recommend cardiac screening
in older patients with Down’s syndrome, for whom new thera-
peutic options are available, and for prevention of cardiac com-
plications in old age.
Stroke was a major cause of morbidity in adult congenital
heart disease in a retrospective analysis of aggregated Euro-
pean and Canadian databases74 with a total of 23 153 patients
aged 16–91 years (mean 36.4). Among them, 458 patients
(2.0%) had one or more cerebrovascular accidents. The highest
prevalence was in cyanotic lesions 50/215 (23.3%).
A meta-analysis and systematic review of atrial septal de-
fect closure identiﬁed 26 studies including 1841 patients who
underwent surgical closure and 945 who underwent percutane-
ous closure.75 Meta-analysis using a random effects model
demonstrated a reduction in the prevalence of atrial tachyar-
rhythmias after atrial septal defect closure (OR = 0.66 (95%
CI 0.57–0.77)). This effect was demonstrated after both percu-
taneous and surgical closure. Immediate (<30 days) and mid-
term (30 days–5 years) follow-up also showed a reduction in
the prevalence of atrial tachyarrhythmias.
Inuzuka et al. reviewed data of 1375 consecutive adult pa-
tients with congenital heart disease (age 33 ± 13 years) who
underwent cardiopulmonary exercise testing at a single centre
over a period of 10 years.76 They showed that cardiopulmo-
nary exercise testing provides strong prognostic information
in adult patients with congenital heart disease. However, they
considered prognostication should be approached differently,
depending on the presence of cyanosis, use of rate-lowering
drugs and achieved level of exercise.
13. Pregnancy and congenital heart disease
Heart disease has become the major factor in maternal mortal-
ity during pregnancy in developed countries. The increasing
number of women with congenital heart disease surviving to
adult life has made care in pregnancy for this group an
26 M. Burch, N. Dedieuimportant area of obstetric cardiology. The care needed for
this vulnerable group has been highlighted.77 The outcomes
of 405 pregnancies of women with congenital heart disease
were investigated and late cardiac events investigated.78 While
adverse events during pregnancy are well known, the problem
of late cardiac events after pregnancy is less well known. The
authors found pre-pregnancy maternal characteristics can help
to identify women at increased risk for late cardiac events. Ad-
verse cardiac events during pregnancy were also important and
are associated with an increased risk of late cardiac events.
Opotowsky et al. used the US national registry of hospital
admissions to assess annual deliveries for women with congen-
ital heart disease.79 These increased 34.9% from 1998 to 2007
compared with an increase of 21.3% in the general population.
Women with congenital heart disease were more likely to sus-
tain a cardiovascular event (4042/100,000 vs. 278/100,000
deliveries); arrhythmia was the most common cardiovascular
event. Death occurred in 150/100,000 patients with congenital
heart disease compared with 8.2/100,000 patients without.
Complex disease was associated with greater odds of having
an adverse cardiovascular event than simple congenital heart
disease (8158/100000 vs. 3166/100,000, multivariable
OR= 2.0, 95% CI 1.4–3.0).
Lui et al., investigated heart rate response during exercise
and pregnancy outcome in women with congenital heart dis-
ease.80 Peak heart rate, percentage of maximum age predicted
heart rate and chronotropic index were associated with a car-
diac event. Neonatal events occurred in 20%. Peak oxygen
consumption was not associated with an adverse pregnancy
outcome. The authors concluded that an abnormal chrono-
tropic response correlates with adverse pregnancy outcomes
in women with congenital heart disease and should be consid-
ered in reﬁning risk stratiﬁcation schemes.14. Global burden of cardiovascular disease
Congenital heart disease in developing countries is clearly
important as the great majority of patients are born there. A
concerning ﬁnding from New Delhi81 is that female gender is
an important determinant of non-compliance with paediatric
cardiac surgery. Their prospective study of 405 cases included
in-depth interviews. They concluded that deep-seated social
factors underlie this gender bias. An interesting overview of
this problem is given by Daljit Singh and colleagues.82 In a
developed country (Taiwan) an investigation of 289 patients
with adult congenital heart disease found that female gender
was associated with poor physical and psychological quality
of life.83 The common denominators for quality of life were
primarily personality trait, psychological distress and family
support, but interestingly, not disease severity.
A patent ductus is an easily treatable lesion but, if un-
treated, large ducts can lead to pulmonary vascular disease.
Late presentation in developing countries means that many pa-
tients have a level of pulmonary hypertension that could make
intervention dangerous. The results from a study in Mexico84
are important and encouraging. They reported 168 patients
with isolated patent ductus arteriosus (PDA) and pulmonary
artery systolic pressure of $50 mmHg. Mean age was
10.3 ± 14.3 years (median 3.9), PDA diameter was
6.4 ± 2.9 mm (median 5.9), and pulmonary artery systolic
pressure was 63.5 ± 16.2 mmHg (median 60). The overallsuccess rate was 98.2%. Follow-up in 145 (86.3%) cases for
37.1 ± 24 months (median 34.1) showed further decrease of
the pulmonary pressure to 30.1 ± 7.7 mm Hg (p< 0.0001).
The authors have shown that in selected cases percutaneous
treatment of hypertensive ductus is safe and effective and that
pulmonary pressures decrease immediately and continue to fall
with time.
15. Images of congenital heart disease
Perhaps one of the most alluring aspects of congenital heart
disease is the aesthetics of the abnormalities. This lends itself
to imaging, and congenital heart images brighten up the pages
of many major cardiac journals. Therefore it seems appropri-
ate to end this Almanac with reference to some of the more
stunning images that reﬂect the key areas in congenital heart
disease that were discussed above, including intervention,85–91
foetal and neonatal,92–95 heart failure and mechanical sup-
port,96 adolescent and adult congenital heart disease,97,98
advanced imaging with MRI and CT99,100 and unusual mor-
phology.101–106 All of which are well worth a look to brighten
up a night catching up on the cardiac journals.
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